AuntMinnie

MARCH 26, 2024

This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

MAY 30, 2023

It represents a new class of purposely engineered, high-affinity PSMA-targeted radiopharmaceuticals based on novel radiohybrid technology, which may offer diagnostic imaging and therapeutic potential. Results demonstrated high detection rates (% positive PET scans) even at low PSA levels.

Diagnostic 75

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 75

Imaging Technology

MAY 2, 2023

For example, results showed that among the subgroup (n=76) of patients in the Evaluable PET Scan Population who had undergone primary treatment with radiation therapy for prostate cancer, the overall patient-level DR was 99% (75/76) and consistently high across the three independent readers (range 93-99%).

Diagnostic 92

Diagnostic Radiopharmaceuticals Imaging Radiation 92